Cancer/Tumor Profiling Market Overview 2023-2028
The global cancer/tumor profiling market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.4 Billion by 2028, exhibiting a growth rate (CAGR) of 9.8% during 2023-2028.Tumor profiling, also known as cancer profiling, is a laboratory technique used to examine a sample of tumor tissue and blood in order to determine the presence of specific genetic components, proteins, or other molecules. The process involves obtaining a sample of the tumor tissue, purifying it, and analyzing the DNA, RNA, and proteins present. This analysis helps doctors improve their diagnoses and make informed decisions about selecting the most effective drug or clinical trial. Additionally, tumor profiling aids in identifying suitable drug therapies when there are no established treatment options based on research.
Cancer/Tumor Profiling Market Trends and Drivers:
Currently, the market is experiencing a notable surge in the demand for cancer or tumor profiling. This approach has proven to be effective in delivering accurate results, enabling patients to receive timely treatment. Consequently, this factor plays a pivotal role in driving market growth. Furthermore, the prevalence of various types of cancer, including cervical, prostate, lung, kidney, colorectal, breast, and ovarian cancers, is on the rise due to unhealthy lifestyles and the consumption of unhealthy diets. These factors also contribute significantly to the market’s expansion. Moreover, the growing trend of excessive smoking and alcohol consumption among young individuals creates a favorable market outlook. Additionally, the increased use of biomarkers in cancer or tumor profiling further fuels the market growth.
Global Cancer/Tumor Profiling Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: Abbott Laboratories, Becton Dickinson and Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Qiagen N.V., Siemens AG and Sysmex Corporation.
The report has segmented the market on the basis of region, cancer type, technology, technique and application.
Breakup by Cancer Type:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma Cancer
- Others
Breakup by Technology:
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- In-Situ Hybridization (ISH)
- Microarray
- Others
Breakup by Technique:
- Genomics
- Proteomics
- Epigenetics
- Metabolomics
Breakup by Application:
- Personalized Medicine
- Diagnostics
- Biomarker Discovery
- Prognostics
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800